A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties. (2018)
Attributed to:
Gene-expression connectivity mapping and its application in phenotypic targeting
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/pds.4345
PubMed Identifier: 29205633
Publication URI: http://europepmc.org/abstract/MED/29205633
Type: Journal Article/Review
Volume: 27
Parent Publication: Pharmacoepidemiology and drug safety
Issue: 1
ISSN: 1053-8569